Skye Bioscience, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
SKYE on Nasdaq
Industry
Pharmaceutical Preparations
Location
11250 El Camino Real, Suite 100, San Diego, CA

Insiders trading volume in the past year

Skye Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Andrew J. Schwab Director $60.1M -$1.75M -2.83% Feb 24, 2025
5AM Partners VII, LLC 10%+ Owner $60.1M -$1.75M -2.83% Sep 11, 2024
Versant Ventures III, LLC 10%+ Owner $9.39M Aug 18, 2023
Emerald Health Sciences Inc. 10%+ Owner $3.17M Nov 10, 2022
Punit Dhillon Chief Executive Officer, Director $1.7M -$414K -19.5% Feb 24, 2025
Paul A. Grayson Director $1.3M -$432K -25% Feb 24, 2025
Kaitlyn Arsenault Chief Financial Officer $838K -$216K -20.5% Feb 24, 2025
Tuan Tu Diep Chief Development Officer $413K -$97.7K -19.1% Feb 24, 2025
Sukhwinder Singh Rai Director $6.04K Jan 5, 2023
Puneet S. Arora Chief Medical Officer $3.83K Feb 24, 2025
Annalisa Jenkins Director $1.19K Feb 24, 2025
Deborah H. Charych Director $1.19K Feb 24, 2025
Karen L. Smith Director $1.19K Feb 24, 2025
Margaret Dalesandro Director $595 Feb 29, 2024
Keith Wayne Ward Director $595 Feb 29, 2024
Praveen Tyle Director $595 Feb 29, 2024
James L. Heppell Director Sep 14, 2021

Recent Insider Transactions by Companies or Individuals for Skye Bioscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.